You are in

/ Home / Research / Clinical Trials / Dana-Farber Clinical Trials

Main Menu

• Research Advances
• Research Collaboratives
• Office of Research
• Departments and Centers
• Dana-Farber/Harvard Cancer Center
• Researcher Directory
• Clinical Trials
  • Dana-Farber Clinical Trials
  • National Clinical Trials
  • Entering a Clinical Trial: Is It Right for You?
  • What Is a Clinical Trial?
• Shared Resources
• Research and Technology Ventures
• Scientific Report
• Office for Human Research Studies
• Postdoc and Graduate Student Affairs Office
• Research Means Hope

Search for more trials

Cervical Cancer Clinical Trials

This list includes current clinical trials for Cervical Cancer offered through Dana-Farber Cancer Institute and other Dana-Farber/Harvard Cancer Center institutions.

1. Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar

   In this research study we are looking to see how vulvar cancer responds to a short course (4-6 weeks) of erlotinib. Another goal of this study is to learn more about the proteins and genes present in vulvar cancer and how they may affect response to erlotinib. Erlotinib treats cancer by preventing cancer cells from growing and multiplying. It does this by blocking certain proteins that are on the surface of some types of cancer cells. Laboratory tests show that vulvar cancer cells have high levels of these proteins.

   Phase: Phase 2
   Diagnosis: Cervical Cancer

2. Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers

   This research study is evaluating a drug called avastin in combination with standard radiation as a possible treatment for treatment for recurrent pelvic-confined gynecological cancer (i.e. endometrial, cervical, vulvar, ovarian or vaginal cancers).

   Phase: Phase 2
   Diagnosis: Ovarian Cancer, Cervical Cancer